What is GWAS and PheWAS?
INTRODUCTION. Genome‐wide association studies (GWAS) and phenome‐wide association studies (PheWAS) have provided powerful methods for investigating the impact of genetic variation on individual drug response and have added extensive knowledge to the understanding of drug targets and effects.
What is PheWAS analysis?
Phenome-wide association studies (PheWAS) analyze many phenotypes compared to a single genetic variant (or other attribute). This method was originally described using electronic medical record (EMR) data from EMR-linked in the Vanderbilt DNA biobank, BioVU, but can also be applied to other richly phenotyped sets.
What is GWAS data?
Genome-wide association studies (GWAS) help scientists identify genes associated with a particular disease (or another trait). This method studies the entire set of DNA (the genome) of a large group of people, searching for small variations, called single nucleotide polymorphisms or SNPs (pronounced “snips”).
Where can I find GWAS summary statistics?
Users can access all summary statistics from the Catalog FTP site, which is updated nightly following submission. They can also be accessed in the tables below (separate tables for the published and unpublished summary statistics). Metadata associated with summary statistics can be downloaded from Downloads.
Why is PheWAS better than GWAS?
A fundamental difference between GWAS and PheWAS designs is the direction of inference: in a PheWAS it is from exposure (the DNA variant) to many possible outcomes, that is, from SNPs to differences in phenotypes and disease risk.
What is eQTL data?
An eQTL is a locus that explains a fraction of the genetic variance of a gene expression phenotype. Standard eQTL analysis involves a direct association test between markers of genetic variation with gene expression levels typically measured in tens or hundreds of individuals.
What do GWAS show?
A genome-wide association study (abbreviated GWAS) is a research approach used to identify genomic variants that are statistically associated with a risk for a disease or a particular trait.
What is GWAS meta analysis?
Meta-analysis is a set of methods that allows the quantitative combination of data from multiple studies. These methods also allow the quantitative evaluation of the consistency or inconsistency/heterogeneity of the results across multiple datasets.
What is GWAS NCBI?
Genome-wide association study (GWAS) is a powerful study design to identify genetic variants of a trait and, in particular, detect the association between common single-nucleotide polymorphisms (SNPs) and common human diseases such as heart disease, inflammatory bowel disease, type 2 diabetes, and psychiatric disorders …
How are LD scores calculated?
LD score is defined as the sum of LD r2 between a variant and all the variants in a region. Any ideas? At minimum, you need to add –ld-window.
What is the difference between QTL and eQTL?
Mapping eQTLs is done using standard QTL mapping methods that test the linkage between variation in expression and genetic polymorphisms. The only considerable difference is that eQTL studies can involve a million or more expression microtraits.
What is the difference between GWAS and PheWAS?
Like GWAS, PheWAS is a hypothesis-generating approach that is challenged by multiple comparison testing.
Why are GWAS SNPs not used in PheWAS?
The use of GWAS SNPs in PheWAS capitalizes on known association data. Unfortunately, the majority of GWAS SNPs, except for the LPLexample given above, are intergenic SNPs with unknown function, making translation of association results into biological insight a challenge.
Are all GWAS included in the meta-analysis for a given phenotype?
Results for SNPs associated with the relevant phenotype with P < 0.05 were included in the meta-analysis. Correlation between all GWAS was estimated to ensure that no GWAS included in the meta-analysis for a given phenotype presented overlapping samples.
What is a PheWAS test?
PheWAS are an unbiased approach to test for associations between a specific genetic variant, or, more recently, combination of variants, and a wide range of phenotypes in large numbers of individuals 7, 15, 16.